VERY POSITIVE that they are taking stock as payment. obviously if management is taking stock instead of cash salary, it puts an extreme strain on their daily lives being cash poor. ive done it in many startups and its no fun and very stressful.

"is it worth it" ?

first it creates disdain for those that have pulled fatter salaries up until this event and can weather the storm with less cash, while i may not be able to as i was paid less and living paycheck to paycheck. in nothern cali, 80k is below minimum wage. a few months of stock for payment and im literally homeless.

second it puts untold stress on those below to overwork and over deliver, for months on end, possibly for zero payout and extreme financial disaster if the finish line cannot be crossed.

huge risk. i personally will never do this again. if it happens again, i will quit immediately, and have... too old for that shit. i got hosed a number of times in the silicon valley "isnt this great" and " isnt it cool to sleep at your desk for weeks on end" and "we're all in it together (no we're not)" mentality. only to hold absolutely worthless stock. because upper management failed and made horrible decisions that i had zero control or input to. never again.

unless i worked at cytodyn today. i would love to be at cytodyn right now. this new NASH data is serious. these people made the calculated risk and it may be marginal here. ill go as far as little to no risk at all. ill go as far as the NDAs alone tell them that the interest in cytodyn is significant and a partnership or sale is inevitable. because the drug works, and others know it. and in a few weeks even more will know it. good on them to be able to conserve company cash on hand for the greater good of future success. risky but worth it.